Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haili Qian

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Journal of Biomedical Science|January 28, 2024
Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapyDantong Sun, Haili Qian, Junling Li, et al.
Leukemia|October 30, 2020
Inhibitors targeting Bruton's tyrosine kinase in cancers: drug development advancesTingyu Wen, Jinsong Wang, Yuankai Shi, et al.
Journal of Gynecologic Oncology|February 14, 2025
Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosisLing Zhong, Ying Lin, Chunxiao Li, et al.
Cancers|September 9, 2022
Prognostic Value of Copy Number Alteration Burden in Early-Stage Breast Cancer and the Construction of an 11-Gene Copy Number Alteration ModelDingyuan Wang, Songlin Gao, Haili Qian, et al.
Anti-Cancer Drugs|February 13, 2016
Adoptive immunotherapy combined chemoradiotherapy for non-small-cell lung cancer: a meta-analysisHaili Qian, Haijuan Wang, Xiuwen Guan, et al.
Archives of Gynecology and Obstetrics|October 3, 2019
The clinical characteristics and prognosis of endometrial carcinomas that occur after breast cancer: does hormone receptor status of breast cancer matter?Jianbin Guo, Ying Zhang, Haili Qian, et al.
Journal of Translational Medicine|July 24, 2025
Exploring UBASH3A: from immune regulation to autoimmune diseasesMeng Zhou, Fangzhou Sun, Zhenguo Zhao, et al.
Medicine|March 18, 2016
The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma: A Meta-Analysis of Clinical Trials Following the PRISMA GuidelinesXiuwen Guan, Haijuan Wang, Fei Ma, et al.
Oncology Letters|September 10, 2014
Prognosis of lymph node-negative breast cancer: Association with clinicopathological factors and tumor associated gene expressionJing He, Haijuan Wang, Fei Ma, et al.
Therapeutic Advances in Medical Oncology|June 27, 2020
The characteristics of isolated para-aortic lymph node metastases in endometrial cancer and their prognostic significanceJianbin Guo, Haili Qian, Fei Ma, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Journal of Biomedical Science|January 28, 2024
Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapyDantong Sun, Haili Qian, Junling Li, et al.
Leukemia|October 30, 2020
Inhibitors targeting Bruton's tyrosine kinase in cancers: drug development advancesTingyu Wen, Jinsong Wang, Yuankai Shi, et al.
Journal of Gynecologic Oncology|February 14, 2025
Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosisLing Zhong, Ying Lin, Chunxiao Li, et al.
Cancers|September 9, 2022
Prognostic Value of Copy Number Alteration Burden in Early-Stage Breast Cancer and the Construction of an 11-Gene Copy Number Alteration ModelDingyuan Wang, Songlin Gao, Haili Qian, et al.
Anti-Cancer Drugs|February 13, 2016
Adoptive immunotherapy combined chemoradiotherapy for non-small-cell lung cancer: a meta-analysisHaili Qian, Haijuan Wang, Xiuwen Guan, et al.
Archives of Gynecology and Obstetrics|October 3, 2019
The clinical characteristics and prognosis of endometrial carcinomas that occur after breast cancer: does hormone receptor status of breast cancer matter?Jianbin Guo, Ying Zhang, Haili Qian, et al.
Journal of Translational Medicine|July 24, 2025
Exploring UBASH3A: from immune regulation to autoimmune diseasesMeng Zhou, Fangzhou Sun, Zhenguo Zhao, et al.
Medicine|March 18, 2016
The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma: A Meta-Analysis of Clinical Trials Following the PRISMA GuidelinesXiuwen Guan, Haijuan Wang, Fei Ma, et al.
Oncology Letters|September 10, 2014
Prognosis of lymph node-negative breast cancer: Association with clinicopathological factors and tumor associated gene expressionJing He, Haijuan Wang, Fei Ma, et al.
Therapeutic Advances in Medical Oncology|June 27, 2020
The characteristics of isolated para-aortic lymph node metastases in endometrial cancer and their prognostic significanceJianbin Guo, Haili Qian, Fei Ma, et al.
Pageof 10